Stock CLAS.H CLARITAS PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Claritas Pharmaceuticals, Inc.

Equities

CLAS.H

CA1806342061

End-of-day quote Toronto S.E.
Other stock markets
 23:00:00 18/07/2022 BST 		5-day change 1st Jan Change
0.025 CAD -16.67% Intraday chart for Claritas Pharmaceuticals, Inc. -.--% -.--%
2021 Claritas Pharmaceuticals : Updates Proposed Financing with Obsidian, Receives Australian Tax Credit, Starts Phase 1 Study of R-107 MT
2021 Claritas Pharmaceuticals, Inc. Announces Data from Study Demonstrating Effectiveness of Nitric Oxide in Patients with Severe Covid-19 Pneumonia as Validation of the Company’s Nitric Oxide-Releasing Compound, R-107 CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Claritas Pharmaceuticals : Updates Proposed Financing with Obsidian, Receives Australian Tax Credit, Starts Phase 1 Study of R-107
Claritas Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021
Claritas Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020
Kalytera Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CLAS.H Stock
  4. News Claritas Pharmaceuticals, Inc.
  5. Other languages